Back to results
US 8,541,201 B2Granted
Thrombopoietic compounds
AssigneeAmgen Inc.
InventorsHosung Min, Kenneth W. Walker, Colin V. Gegg, Francesco Galimi, Jeonghoon Sun, Mei-Mei Tsai
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of compounds, especially peptides or polypeptides, that have thrombopoietic activity. The peptides and polypeptides of the invention may be used to increase platelets or platelet precursors (e.g., megakaryocytes) in a mammal.
Claims4
An isolated polynucleotide that encodes a compound that binds to an mpl receptor, wherein said compound is selected from the group consisting of SEQ ID NOS:
- 353-422.
Dependencies are inferred from the claim text.